Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-18 2022-04-06 156987
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-25 2022-04-01 157298
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-12-17 159703
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-27 2022-06-03 161442
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-OXYCODONE CR 5.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-09-23 165332
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-01-26 177612
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2022-12-16 177672
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772

Showing 2901 to 2920 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2019-08-08 60420
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2019-08-07 2019-08-07 91117
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4909
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-09-08 2018-09-15 60867

Showing 341 to 356 of 356